4.000
+0,00%
2026-10-15
Fundamental Analysis
93 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +314.3% | +1483.2% | 3 / 3 | +35.5% | +37.26 pp | +7.70 pp | +16.1% | 0.13 | 4.36 | 32,2 | +35,5% | 3,7 | +314,3% | 4.36 | 11.62 | −62,5% |
| Pts | 12 | 12 | 12 | 12 | 12 | 12 | 4 | 12 | 12 | |||||||
Valuation annotation:Price: 4.000 (close price on 2026-10-15)EPS (TTM): 917,3
Financial charts
1.Revenue & growth
VND bn32,2Q2/26
1.Revenue & growth
VND bn32,2Q2/26
2.Profit & growth
VND bn3,68Q2/26
3.Profit mix (Penman)
VND bn13,2Q2/26
4.Margins & cost structure
%17.0%Q2/26
5.Returns & cash cycle
% · days-7.4%Q2/26
6.Earnings quality & cash
VND bn49,9Q2/26
7.Asset structure
VND bn213Q2/26
8.Funding & debt health
VND bn · times213Q2/26
9.Revenue backlog
VND bn21,4Q2/26
10.Valuation
times · %4,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %255Q2/26
Adjusted EPS growth, latest quarter
314%
Average adjusted EPS growth, 3 quarters
15,8× higher
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26